19 companies

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$9.90

7D

-1.5%

1Y

28.4%

Verano Holdings

Market Cap: CA$586.7m

Engages in the cannabis business in the United States.

VRNO

CA$8.30

7D

-1.0%

1Y

124.3%

Eupraxia Pharmaceuticals

Market Cap: CA$567.0m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

EPRX

CA$9.27

7D

-2.0%

1Y

28.7%

Canopy Growth

Market Cap: CA$553.0m

Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.

New

WEED

CA$1.34

7D

-2.2%

1Y

-10.1%

Cresco Labs

Market Cap: CA$463.2m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

CL

CA$1.05

7D

-2.8%

1Y

34.6%

Spectral Medical

Market Cap: CA$402.0m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

EDT

CA$1.42

7D

5.2%

1Y

73.2%

TerrAscend

Market Cap: CA$283.5m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

TSND

CA$0.76

7D

-6.2%

1Y

58.3%

High Tide

Market Cap: CA$262.7m

Engages in the cannabis retail business in Canada, the United States, and internationally.

HITI

CA$3.15

7D

1.0%

1Y

-6.8%

Aurora Cannabis

Market Cap: CA$225.5m

Engages in the production, distribution, and sale of cannabis products in Canada and internationally.

ACB

CA$3.70

7D

-4.1%

1Y

-40.5%

Cardiol Therapeutics

Market Cap: CA$200.6m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

CRDL

CA$1.69

7D

17.4%

1Y

5.0%

Organigram Global

Market Cap: CA$173.2m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

OGI

CA$1.25

7D

-8.8%

1Y

-37.8%

HLS Therapeutics

Market Cap: CA$130.1m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.

HLS

CA$4.11

7D

-4.6%

1Y

-16.1%

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

DB

CA$0.11

7D

0%

1Y

10.0%

Vext Science

Market Cap: CA$61.9m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

VEXT

CA$0.26

7D

10.9%

1Y

50.0%

Sernova Biotherapeutics

Market Cap: CA$41.5m

Operates as a clinical-stage biotechnology company in Canada.

SVA

CA$0.12

7D

-8.0%

1Y

-32.4%

Optimi Health

Market Cap: CA$39.3m

Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

OPTI

CA$7.00

7D

7.9%

1Y

45.8%

Medicenna Therapeutics

Market Cap: CA$32.3m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

MDNA

CA$0.35

7D

-5.4%

1Y

-58.3%

Rubicon Organics

Market Cap: CA$30.4m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

ROMJ

CA$0.45

7D

0%

1Y

2.3%

Delivra Health Brands

Market Cap: CA$3.1m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.

DHB

CA$0.09

7D

-14.3%

1Y

-60.9%